Development of a nanoparticle controlled-release formulation for human use

Verdun, C.; Couvreur, Patrick; Vranckx, Henri; Lenaerts, Vincent; Roland, M

doi:10.1016/0168-3659(86)90081-7

Cited by 72 publications

(29 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The MRT of Dox delivered through DP nanoparticles was lower than for the Dox solution, while that for Dox delivered through EP nanoparticles was higher than for Dox solution. The AUC [0][1][2][3][4][5][6][7][8] , AUC 0-∞ and AUMC 0-8 of Dox delivered through nanoparticles were significantly higher than for Dox solution. The bioavailability of Dox was greatly enhanced by DP (1.9 fold) and EP nanoparticles (2.12 fold).…”

Section: Resultsmentioning

confidence: 99%

“…These nanoparticles alter the body distribution of incorporated drugs 3 , protect the drugs against enzymatic degradation 4 , and reduce the toxic effects of drug molecules. 5 Majority of the earlier studies reported the dispersion polymerization technique for the synthesis of PBC nanoparticles. [6][7][8] We have recently reported the synthesis of PBC nanoparticles of smaller size by emulsion polymerization technique.…”

Section: Introductionmentioning

confidence: 99%

“…routes and the respective pharmacokinetics and tissue distribution were determined. Both types of nanoparticles significantly enhanced the elimination half-life (T 1/2 ), mean residence time (MRT) AUC [0][1][2][3][4][5][6][7][8] , AUC 0-∞ and AUMC 0-8 of Dox in blood after i.v. injection.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Pharmacokinetics and Biodistribution Studies of Doxorubicin Loaded Poly(butyl Cyanoacrylate) Nanoparticles Synthesized by Two Different Techniques

Reddy¹,

Murthy²

2004

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub

View full text Add to dashboard Cite

The aim of the study is to determine and compare the pharmacokinetics and tissue distribution of Doxorubicin (Dox) delivered as solution or through nanoparticles after intravenous (i.v.) and intraperitoneal (i.p.) injection. Doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles were synthesized by dispersion polymerization (DP) and emulsion polymerization (EP) techniques. The drug loaded DP and EP nanoparticles were administered by i.v. or i.p. routes and the respective pharmacokinetics and tissue distribution were determined. Both types of nanoparticles significantly enhanced the elimination half-life (T 1/2 ), mean residence time (MRT) AUC [0][1][2][3][4][5][6][7][8] , AUC 0-∞ and AUMC 0-8 of Dox in blood after i.v. injection. Dox delivered through DP nanoparticles rapidly disappeared from blood and distributed to the organs of reticuloendothelial system (RES). But, the clearance of Dox delivered through EP nanoparticles from blood was slower than this of the DP nanoparticles and Dox solution. After i.p. injection, the Dox loaded into DP nanoparticles quickly appeared in blood and undergone rapid distribution to the organs of RES, while the Dox loaded into EP nanoparticles absorbed slowly into blood and remained in the circulation for longer time. The absorption into blood of Dox delivered through DP and EP nanoparticles after i.p. injection was relatively rapid and higher than Dox solution. The T 1/2 , MRT, AUC [0][1][2][3][4][5][6][7][8] , AUC 0-∞ and AUMC 0-8 of Dox in blood were significantly higher and the clearance (Cl) was lower than for the Dox solution after i.p. injection. The tissue concentrations of Dox delivered through nanoparticles after i.p. injection were significantly lower than after i.v. injection. The bioavailability (F) of Dox was greatly enhanced by DP (∼1.9 fold) and EP nanoparticles (∼2.12 fold) compared to Dox solution after i.p. injection. EP nanoparticles significantly enhanced the bioavailability, MRT, T 1/2 , AUC 0-8 , AUC 0-∞ and AUMC 0-8 of Dox than DP nanoparticles. This signifies the advantage of EP nanoparticles in increasing the elimination half-life of Dox both after i.v. and i.p. injection and enhanced bioavailability after i.p. injection, which is expected to improve the therapeutic efficacy of Dox and reduce the Dox-associated systemic toxicity. Importantly, both DP and EP nanoparticles greatly reduced the distribution of Dox to heart both after i.v. and i.p. injection, suggesting their potential in reducing Dox-associated cardiotoxicity.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacokinetics and Biodistribution Studies of Doxorubicin Loaded Poly(butyl Cyanoacrylate) Nanoparticles Synthesized by Two Different Techniques

Reddy¹,

Murthy²

2004

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub

View full text Add to dashboard Cite

show abstract

“…7,8 Polymers decrease the gastrointestinal side effects, toxicity of drugs, 9,10 or the dermal irritation of some skin products. 11 Polymers could be employed in target therapy of cancers, 12 masking of the unfavored taste of some drugs, avoidance of the fast elimination of drugs, production of the pH resistant formulations, [13][14][15] and formulation of the injectable form of some drugs that cannot be formulated using common methods.…”

Section: Introductionmentioning

confidence: 99%

Effects of Different Concentrations of Poly(vinyl pyrrolidone) on the Solubility of Lamotrigine and Diazepam in Ethanol + Water Mixtures at 298.2 K

2009

View full text Add to dashboard Cite

The effects of poly(vinyl pyrrolidone) K30 (PVP) (1) on the solubility of lamotrigine (2) and diazepam (2) at 298.2 K are reported for ethanol (3) + water (4) mixtures at five different concentrations (0.0001, 0.0005, 0.001, 0.005 and 0.01) g · mL -1 of PVP. The general version of the Jouyban-Acree model was fitted to the solubility data of each drug in a given concentration of PVP. The largest mean relative deviation (MRD) was 14 %, that is, for diazepam in the presence of (0.0005 and 0.001) g · mL -1 of PVP, and the lowest MRD was 4 % for lamotrigine in the presence of 0.01 g · mL -1 of PVP. The overall MRD for lamotrigine and diazepam was 9 %. A modified version of the Jouyban-Acree model was used to model the simultaneous effects of the ethanol and PVP on the solubility employing experimental solubility of drugs in water and ethanol in the absence of PVP. The MRDs for diazepam and lamotrigine were 23 % and 10 %, respectively, with the overall value of 17 %.

show abstract

“…Firstly, synthesis of such NPs was reported by Couvreur et al [12]. Afterwards, several studies were reported around molecular weight distribution, toxicity, pharmacokinetics, bio distribution, stability and conjugation of different drugs [11,[15][16][17][18][19][20][21].…”

Section: Introductionmentioning

confidence: 99%

Polybutylcyanoacrylate Nanoparticles and Drugs of the Platinum Family: Last Status

et al. 2013

View full text Add to dashboard Cite

Cisplatinum and carboplatinum drugs from platinum-containing family are anti-cancer drugs. Using these drugs causes side effects. Targeted and selective prescription decreases side effects of the drugs. This can be achieved using nanotechnology. In this study, cisplatinum and carboplatinum drugs were loaded on polybutylcyanoacrylate nanoparticles using emulsion polymerization method. To determine amount of loaded drug onto nanoparticle, spectrophotometry method was used. Evaluation of cytotoxicity of such nanoparticles was performed on MCF-7 cell line using MTT assay. Loading percentage of cisplatinum and carboplatinum drugs on nanoparticles were estimated 4 and 6 %, respectively. Cytotoxicity survival rate for cisplatinum and nanoparticle containing cisplatinum at the lowest concentration (p \ 0.01) (20 lM) were estimated 64 ± 1 and 67 ± 0.5 %, respectively. These values at the highest concentration (p \ 0.01) (160 lM) were measured 28 ± 0.7 and 31 ± 0.4 %. Additionally for carboplatinum and nanoparticles containing carboplatinum at the concentration (p \ 0.01) (20 lM) amounts were estimated to be 80 ± 0.6 and 84 ± 0.6 %, while at the concentration (p \ 0.01) (160 lM) were identified to be 44 ± 0.5 and 51 ± 0.2 %, respectively. Probably, due to low level of loading, cytotoxicity of both drugs at nano particle status was decreased in comparison with their standard form.

show abstract

Development of a nanoparticle controlled-release formulation for human use

Cited by 72 publications

References 12 publications

Pharmacokinetics and Biodistribution Studies of Doxorubicin Loaded Poly(butyl Cyanoacrylate) Nanoparticles Synthesized by Two Different Techniques

Pharmacokinetics and Biodistribution Studies of Doxorubicin Loaded Poly(butyl Cyanoacrylate) Nanoparticles Synthesized by Two Different Techniques

Effects of Different Concentrations of Poly(vinyl pyrrolidone) on the Solubility of Lamotrigine and Diazepam in Ethanol + Water Mixtures at 298.2 K

Polybutylcyanoacrylate Nanoparticles and Drugs of the Platinum Family: Last Status

Contact Info

Product

Resources

About